U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
CONCIZUMAB
68603V9EAF
US Approved Rx (2024)
First approved in 2024
General
Record Details
Names
15
Classification
3
Identifiers
6
Subunits
4
Disulfide Links
16
Glycosylation
2
Relationships
1
Active Moiety
1
Characteristic Attributes
2
CONCIZUMAB
68603V9EAF
US Approved Rx (2024)
First approved in 2024
General
Approval Year
2024
52
Record Details
Substance Class
Protein
Protein Type
MONOCLONAL ANTIBODY
Protein Sub Type
IGG1
Sequence Origin
HUMANIZED MOUSE
Sequence Type
COMPLETE
Record UNII
68603V9EAF
Record Status
Validated (UNII)
Record Version
23
22
21
20
19
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
Names
15
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
CONCIZUMAB
Official Name
English
NN7415
Code
English
CONCIZUMAB [USAN]
Common Name
English
Concizumab [WHO-DD]
Common Name
English
NN-7415
Code
English
Showing 1 to 5 of 15 entries
Previous
1
2
3
Next
Classification
3
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of hemophilia A
FDA ORPHAN DRUG
653618
Designated
ORPHAN DRUG
Designated
Treatment of hemophilia B
FDA ORPHAN DRUG
663618
Positive
EU ORPHAN DRUG
Positive
Treatment of haemophilia B
EU-Orphan Drug
EU/3/17/1940
Showing 1 to 3 of 3 entries
Previous
1
Next
Identifiers
6
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
USAN
HI-127
PRIMARY
INN
9636
PRIMARY
DRUG BANK
DB12820
PRIMARY
NCI_THESAURUS
C166914
PRIMARY
CAS
1312299-39-0
PRIMARY
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Subunits
4
Disulfide Links
16
Show
5
20
100
All
entries
From
To
From
To
1_22
1_96
1_148
1_204
1_262
1_322
1_368
1_426
2_22
2_96
Showing 1 to 5 of 16 entries
Previous
1
2
3
4
Next
Glycosylation
2
Show
5
20
100
All
entries
Glycosylation Link Type
Site
Glycosylation Link Type
Site
N
1_298
N
2_298
Showing 1 to 2 of 2 entries
Previous
1
Next
Relationships
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
E1U4X64NFM
TISSUE FACTOR PATHWAY INHIBITOR
TARGET -> INHIBITOR
Amount:
Showing 1 to 1 of 1 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
68603V9EAF
CONCIZUMAB
ACTIVE MOIETY
Amount:
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
2
Show
5
20
100
All
entries
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
MOL_WEIGHT:NUMBER(CALCULATED)
CHEMICAL
ESTIMATED 146000 Da (average)
Molecular Formula
CHEMICAL
ESTIMATED
C6462H9988N1712O2046S46
Showing 1 to 2 of 2 entries
Previous
1
Next
